📗 Cite This Artifact
Events
Overview
This index provides a navigation layer for the events section of NeuroWiki, covering conference proceedings, scientific meetings, and industry events relevant to neurodegenerative disease research (Alzheimer's disease, Parkinson's disease, ALS, and related disorders).
_Total: 124 pages_
AAIC — Alzheimer's Association International Conference
...
Overview
This index provides a navigation layer for the events section of NeuroWiki, covering conference proceedings, scientific meetings, and industry events relevant to neurodegenerative disease research (Alzheimer's disease, Parkinson's disease, ALS, and related disorders).
_Total: 124 pages_
AAIC — Alzheimer's Association International Conference
- [AAIC 2025 Conference](/events/aaic-2025)
- [AAIC 2026 Conference](/events/aaic-2026)
- [AAIC 2026: Biomarker-Guided Clinical Trials](/events/aaic-2026/biomarker-clinical-trials)
- [AAIC 2026: Multi-Modal Biomarker Integration](/events/aaic-2026/biomarker-integration)
- [Blood-Based Biomarkers Validation](/events/aaic-2026/biomarker-integration/blood-biomarkers-validation)
- [Clinical Utility of Integrated Biomarker Panels](/events/aaic-2026/biomarker-integration/clinical-utility)
- [Digital Biomarkers and Wearable Integration](/events/aaic-2026/biomarker-integration/digital-wearables)
- [PET Imaging Combined with Fluid Biomarkers](/events/aaic-2026/biomarker-integration/pet-fluid-combination)
- [Statistical Methods for Biomarker Combinations](/events/aaic-2026/biomarker-integration/statistical-methods)
- [AAIC 2026: Cellular Pathophysiology and Neurodegeneration Biomarkers in Alzheimer's Disease](/events/aaic-2026/cellular-pathophysiology-alzheimers)
- [AAIC 2026: Clinical Trial Updates](/events/aaic-2026-clinical-trials)
- [AAIC 2026: Clinical Trials and Drug Development](/events/aaic-2026/clinical-trials-update)
- [AAIC 2026 Company Presentations](/events/aaic-2026-company-presentations)
- [AAIC 2026: Early Detection and Preclinical AD](/events/aaic-2026/early-detection)
- [AAIC 2026: Emerging Therapeutic Targets](/events/aaic-2026-emerging-therapeutic-targets)
- [AAIC 2026: Epigenetic Mechanisms in Alzheimer's](/events/aaic-2026-epigenetic-mechanisms)
- [AAIC 2026: Fluid Biomarkers](/events/aaic-2026/fluid-biomarkers)
- [AAIC 2026: Gene Therapy Developments](/events/aaic-2026/gene-therapy-developments)
- [AAIC 2026: Glial Cell Mechanisms](/events/aaic-2026/glial-cell-mechanisms)
- [AAIC 2026: Imaging Advances](/events/aaic-2026/imaging-advances)
- [AAIC 2026: Immunotherapy and Antibody Therapeutics Update](/events/aaic-2026/immunotherapy-update)
- [AAIC 2026 ISTAART Sessions](/events/aaic-2026-istaart-sessions)
- [AAIC 2026: Lifestyle Factors and Prevention](/events/aaic-2026/lifestyle-factors)
- [AAIC 2026: Metabolic Approaches](/events/aaic-2026/metabolic-approaches)
- [AAIC 2026: Neuroimaging and Biomarker Advances](/events/aaic-2026/neuroimaging-biomarkers)
- [AAIC 2026: Neuroinflammation](/events/aaic-2026/neuroinflammation)
- [AAIC 2026: Neuroinflammation & Microglia in Alzheimer's](/events/aaic-2026-neuroinflammation)
- [AAIC 2026: Novel Therapeutic Targets and Disease-Modifying Approaches](/events/aaic-2026-novel-therapeutic-targets)
- [AAIC 2026: Plenary Sessions](/events/aaic-2026-plenary-sessions)
- [AAIC 2026: Poster and Abstract Highlights](/events/aaic-2026-posters-abstracts)
- [AAIC 2026: Prevention Trials](/events/aaic-2026/prevention-trials)
- [AAIC 2026: Satellite Symposia and Sponsors](/events/aaic-2026-satellite-symposia)
- [AAIC 2026: Scientific Sessions](/events/aaic-2026-scientific-sessions)
- [AAIC 2026: Synaptic Function Preservation](/events/aaic-2026/synaptic-function-preservation)
- [AAIC 2026: Tau Imaging and Biomarker Validation Studies](/events/aaic-2026-tau-imaging-biomarker-validation)
- [AAIC 2026: Tau Immunotherapy](/events/aaic-2026-tau-immunotherapy)
- [AAIC 2026: Therapeutic Antibodies and Immunotherapy Advances](/events/aaic-2026/therapeutic-antibodies)
- [AAIC 2026: Therapeutic Approaches](/events/aaic-2026/therapeutic-approaches)
AAN — American Academy of Neurology
- [AAN Annual Meeting 2025](/events/aan-2025)
- [AAN Annual Meeting](/events/aan-annual-meeting)
- [AAN 2026 — American Academy of Neurology Annual Meeting](/events/aan-2026)
- [AAN 2026 — Alzheimer's Disease](/events/aan-2026/alzheimers-disease)
- [AAN 2026 — Dementia](/events/aan-2026/dementia)
- [AAN 2026 — Parkinson's Disease](/events/aan-2026/parkinsons-disease)
AD/PD — International Conference on Alzheimer's and Parkinson's Diseases
- [AD/PD 2025 Conference](/events/adpd-2025)
- [AD/PD 2026 Conference](/events/adpd-2026)
- [AD/PD 2026 Clinical Trial Updates](/events/adpd-2026-clinical-trials)
- [AD/PD 2026 Company Presentations](/events/adpd-2026-company-presentations)
- [AD/PD 2026: Emerging Therapeutic Targets](/events/adpd-2026-emerging-therapeutic-targets)
- [AD/PD 2026: Gene Therapy](/events/adpd-2026-gene-therapy)
- [AD/PD 2026: Immunotherapy](/events/adpd-2026-immunotherapy)
- [AD/PD 2026: ISTAART Sessions](/events/adpd-2026-istaart-sessions)
- [AD/PD 2026: Neuroinflammation](/events/adpd-2026-neuroinflammation)
- [AD/PD 2026: Plenary Sessions](/events/adpd-2026-plenary-sessions)
- [AD/PD 2026: Poster and Abstract Highlights](/events/adpd-2026-posters-abstracts)
- [AD/PD 2026: Key Researchers and Thought Leaders](/events/adpd-2026-researchers)
- [AD/PD 2026: Satellite Symposia and Sponsors](/events/adpd-2026-satellite-symposia)
- [AD/PD 2026: Scientific Sessions](/events/adpd-2026-scientific-sessions)
CTAD — Clinical Trials on Alzheimer's Disease
- [CTAD Conference](/events/ctad)
- [CTAD 2025 Conference](/events/ctad-2025)
- [CTAD 2026 — Clinical Trials on Alzheimer's Disease](/events/ctad-2026)
- [CTAD 2026: Amyloid-Targeting Antibody Trial Results](/events/ctad-2026-amyloid-antibody-trials)
- [CTAD 2026: Anti-Tau Therapy Updates](/events/ctad-2026-tau-immunotherapy)
MDS — International Parkinson and Movement Disorder Society
- [MDS 2026](/events/mds-2026)
- [Deep Brain Stimulation Updates — MDS 2026](/events/mds-2026/deep-brain-stimulation-updates)
- [Movement Disorder Management — MDS 2026](/events/mds-2026/movement-disorder-management)
- [MDS 2026 — Advanced Neuroimaging in Movement Disorders](/events/mds-2026-advanced-neuroimaging)
- [MDS 2026 — Alpha-Synuclein & Lewy Body Research](/events/mds-2026-alpha-synuclein-lewy-body)
- [MDS 2026 — Fluid Biomarker Advances in Neurodegeneration](/events/mds-2026-fluid-biomarker-advances)
- [MDS 2026 — GBA and LRRK2 Genetic Susceptibility in Parkinson's Disease](/events/mds-2026-gba-lrrk2-genetic-susceptibility)
- [MDS 2026 — Huntington's Disease Sessions](/events/mds-2026-huntingtons-sessions)
- [MDS 2026 — Industry Pipeline](/events/mds-2026-industry-pipeline)
- [MDS 2026 — Parkinson's Disease Diagnostics & Biomarkers](/events/mds-2026-parkinsons-diagnostics-biomarkers)
- [MDS 2026 — Emerging Therapeutics in Parkinson's Disease](/events/mds-2026-parkinsons-emerging-therapeutics)
- [MDS 2026 — Motor Complications in Parkinson's Disease](/events/mds-2026-parkinsons-motor-complications)
- [MDS 2026 — Non-Motor Symptoms in Parkinson's Disease](/events/mds-2026-parkinsons-non-motor-symptoms)
- [MDS 2026 — Parkinson's Disease Clinical Advances](/events/mds-2026-parkinsons-sessions)
- [MDS 2026 — Sleep and Circadian Disorders in Parkinson's Disease](/events/mds-2026-parkinsons-sleep-circadian)
- [MDS 2026 — Prodromal and Early-Onset Parkinson's Biomarkers](/events/mds-2026-prodromal-early-onset-parkinson-biomarkers)
- [MDS 2026 — Alpha-Synuclein Propagation & Seeding Biomarkers](/events/mds-2026/propagation-seeding-biomarkers)
- [PD Clinical Trials — MDS 2026](/events/mds-2026/parkinsons-clinical-trials)
- [Dysautonomia and Non-Motor Complications in PD — MDS 2026](/events/mds-2026/parkinsons-dysautonomia-non-motor)
- [Non-Motor Symptoms in PD — MDS 2026](/events/mds-2026/parkinsons-non-motor-symptoms)
- [MDS 2026 — Tremor and Hyperkinetic Movement Disorders](/events/mds-2026/tremor-hyperkinetic-movements)
- [MDS 2026 — Rare Movement Disorders](/events/mds-2026-rare-movement-disorders)
SfN — Society for Neuroscience
- [SfN Annual Meeting 2025](/events/sfn-2025)
- [SfN Annual Meeting](/events/sfn-annual-meeting)
- [SfN Neuroscience 2026 — Neurodegeneration Research Highlights](/events/sfn-2026)
- [SfN 2026: Glial Biology in Neurodegeneration](/events/sfn-2026/glial-biology)
- [SfN 2026: Neural Circuit Research in Neurodegeneration](/events/sfn-2026/neural-circuits)
- [SfN 2026: Neurodegeneration Sessions](/events/sfn-2026/neurodegeneration)
WPC — World Parkinson Congress
- [World Parkinson Congress](/events/world-parkinson-congress)
- [World Parkinson Congress 2025](/events/world-parkinson-congress-2025)
- [WPC 2026](/events/world-parkinson-congress-2026)
Other Events
- [Brain Health Roundtable and AADAPT Act: 2026 Dementia Care Policy Initiatives](/events/brain-health-roundtable-aadapt-act)
- [Conference Index](/events/conference-index)
- [International Congress on Parkinson's Disease](/events/international-congress-parkinsons-disease)
Related Sections
- [Diseases](/diseases) — Disease-focused conferences
- [Therapeutics](/therapeutics) — Clinical trial announcements](/therapeutics)
- [Researchers](/researchers) — Researchers presenting at events](/events)
- [Companies](/companies) — Company presentations at conferences
Related Hypotheses
From the [SciDEX Exchange](/exchange) — scored by multi-agent debate
- [CYP46A1 Overexpression Gene Therapy](/hypothesis/h-2600483e) — <span style="color:#81c784;font-weight:600">0.79</span> · Target: CYP46A1
- [Gamma entrainment therapy to restore hippocampal-cortical synchrony](/hypothesis/h-bdbd2120) — <span style="color:#81c784;font-weight:600">0.77</span> · Target: SST
- [Hippocampal CA3-CA1 circuit rescue via neurogenesis and synaptic preservation](/hypothesis/h-856feb98) — <span style="color:#81c784;font-weight:600">0.73</span> · Target: BDNF
- [Senescent Microglia Resolution via Maresins-Senolytics Combination](/hypothesis/h-3f02f222) — <span style="color:#81c784;font-weight:600">0.72</span> · Target: BCL2L1
- [Phase-Separated Organelle Targeting](/hypothesis/h-ec731b7a) — <span style="color:#81c784;font-weight:600">0.72</span> · Target: G3BP1
- [Transcriptional Autophagy-Lysosome Coupling](/hypothesis/h-ae1b2beb) — <span style="color:#81c784;font-weight:600">0.72</span> · Target: FOXO1
- [Adenosine-Astrocyte Metabolic Reset](/hypothesis/h-41bc2d38) — <span style="color:#81c784;font-weight:600">0.71</span> · Target: ADORA2A
- [Stress Granule Phase Separation Modulators](/hypothesis/h-97aa8486) — <span style="color:#81c784;font-weight:600">0.71</span> · Target: G3BP1
Related Analyses:
- [Astrocyte reactivity subtypes in neurodegeneration](/analysis/SDA-2026-04-01-gap-007) 🔄
- [Blood-brain barrier transport mechanisms for antibody therapeutics](/analysis/SDA-2026-04-01-gap-008) 🔄
- [Microglia-astrocyte crosstalk amplification loops in neurodegeneration](/analysis/SDA-2026-04-01-gap-009) 🔄
- [APOE4 structural biology and therapeutic targeting strategies](/analysis/SDA-2026-04-01-gap-010) 🔄
- [Autophagy-lysosome pathway convergence across neurodegenerative diseases](/analysis/SDA-2026-04-01-gap-011) 🔄
▸Metadataorigin_type: v1_polymorphic_backfill
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-16908b0605f2 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'events'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-events?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[Events](http://scidex.ai/artifact/wiki-events)
http://scidex.ai/artifact/wiki-events